Prudential Financial Inc I Teos Therapeutics, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 253,291 shares of ITOS stock, worth $2.14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

253,291

Previous 230,491 9.89%

Holding current value

$2.14 Million

Previous $3.42 Million 24.39%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.09 - $17.97 $230,052 - $409,716	22,800 Added 9.89%	253,291 $2.59 Million
Q2 2024 Aug 13, 2024	SELL	$10.33 - $18.09 $117,762 - $206,226	-11,400 Reduced 4.71%	230,491 $3.42 Million
Q1 2024 May 14, 2024	SELL	$9.89 - $13.64 $999,879 - $1.38 Million	-101,100 Reduced 29.48%	241,891 $3.3 Million
Q4 2023 Feb 13, 2024	BUY	$8.57 - $11.06 $782,355 - $1.01 Million	91,290 Added 36.27%	342,991 $3.76 Million
Q3 2023 Nov 13, 2023	SELL	$10.95 - $14.6 $430,882 - $574,510	-39,350 Reduced 13.52%	251,701 $2.76 Million
Q2 2023 Aug 11, 2023	BUY	$12.93 - $18.05 $1.73 Million - $2.41 Million	133,690 Added 84.96%	291,051 $3.85 Million
Q1 2023 May 12, 2023	BUY	$13.02 - $22.62 $147,126 - $255,606	11,300 Added 7.74%	157,361 $2.14 Million
Q4 2022 Feb 14, 2023	BUY	$17.77 - $21.6 $21,324 - $25,920	1,200 Added 0.83%	146,061 $0
Q3 2022 Nov 04, 2022	BUY	$18.6 - $27.25 $601,803 - $881,673	32,355 Added 28.76%	144,861 $2.76 Million
Q2 2022 Aug 15, 2022	SELL	$16.57 - $35.1 $896,685 - $1.9 Million	-54,115 Reduced 32.48%	112,506 $2.32 Million
Q1 2022 May 13, 2022	BUY	$31.92 - $47.45 $3.51 Million - $5.22 Million	109,991 Added 194.23%	166,621 $5.36 Million
Q4 2021 Feb 14, 2022	BUY	$26.23 - $47.86 $1.49 Million - $2.71 Million	56,630 New	56,630 $2.64 Million

Others Institutions Holding ITOS

# of Institutions

165

Shares Held

36.5M

Call Options Held

890K

Put Options Held

374K

View Full List

About iTeos Therapeutics, Inc.

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $301M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

More about ITOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc I Teos Therapeutics, Inc. Transaction History